Upcoming Webinar

Integrating Expert Opinions: Why Your Clinical Trial Needs an EAC

Evaluating clinical trial endpoints can be complex and require a fair bit of expert judgment. Independent endpoint adjudication committees (EACs) provide necessary support to sponsors and contract research organizations (CROs), focusing on the evaluation of specific medical events and outcomes in clinical trials.

These committees are increasingly best practice to provide an independent, expert evaluation of clinical trial events and an unbiased adjudication to determine if an endpoint has been met.

In this webinar, James Riddle, Advarra Vice President of Research Services & Strategic Consulting, and Barbara Schneider, Advarra Executive Director of Biostatistical Services, discuss the role and function of independent EACs, from charter creation through end of study closeout. They also outline the regulatory guidelines governing when EACs are recommended and prepare you to work collaboratively with an independent EAC on your next trial.

Learning Objectives:

  • Define the basic Food and Drug Administration (FDA) and European Medicines Agency (EMA) guidelines governing when EACs should be considered for clinical trials
  • Outline key takeaways to prepare your research program for engaging collaboratively with an independent EAC
  • Explain the role of the EAC and how their oversight is different than the data monitoring committee (DMC/DSMB) and the institutional review board (IRB)
  • Describe the difference between an EAC and the sponsor’s medical monitor

Presented By

James Riddle.png

James Riddle

MCSE, CIP, CPIA, CRQM

Vice President, Research Services & Strategic Consulting
Advarra

Kindra Cooper.png

Barbara Schneider

PhD, MBA

Executive Director, Biostatistical Services
Advarra

Empty Image Placeholder

n/a

n/a

n/a
n/a

Empty Image Placeholder

n/a

n/a

n/a
n/a

 

Who should watch?

This content applies to research professionals representing sponsors, CROs, and institutions who are involved in the planning, development, and execution of clinical drug and device trials.

CE Credits

This event may qualify for continuing education (CE) credits. Please check with your professional organization(s) to determine whether the event meets their CE eligibility requirements.

Certificate of Attendance

After watching this webinar in its entirety and completing the webinar survey, you will receive a certificate of attendance. This certificate will be emailed to you within one business day of watching the webinar. Please note that if your organization has other staff members who wish to get a certificate of attendance, each person must register, watch the webinar in its entirety, and complete the webinar survey. Visit our Webinar Help page for more information on certificates of attendance.

DATE: February 17, 2022
Time: 1 pm ET | 10 am PT
Duration: 1 hour

Register Now